Skip to content

Other segment segments

TriLink
$12.21M

Similar metrics at other companies

S&P Global logo
SPGIIndices — Acquisitions
$9M
Granite Construction logo
GVAConstruction — Acquisitions
$16.65M+1,414%
ABM Industries logo
ABMBusiness & Industry — Acquisitions
$0
Tetra Tech logo
TTEKCIG — Acquisition activity
$9.15M
Stewart Information Services logo
STCCorporate — Acquisitions
$0
Ares Management Corporation logo
ARESCredit Group — Acquisitions
$0

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s cygnus — acquisitions?
Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — acquisitions of $0 in Q4 2025.
What does cygnus — acquisitions mean?
Captures the capital expenditure or investment outlays directed toward acquiring new businesses or assets specifically integrated into the Cygnus segment. This metric is a key indicator of the company's inorganic growth strategy and its commitment to expanding the segment's market capabilities.